Contact
Please use this form to send email to PR contact of this press release:
Nexien BioPharma and Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies
TO:
Mark Lubchenco
Nexien BioPharma Inc
303 495 7583